Orthofix Medical Inc. (OFIX)

Market Cap	685.94M
Revenue (ttm)	784.25M
Net Income (ttm)	-119.03M
Shares Out	38.21M
EPS (ttm)	-3.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	140,277
Open	18.21
Previous Close	18.10
Day's Range	17.72 - 18.21
52-Week Range	12.08 - 20.73
Beta	1.10
Analysts	Strong Buy
Price Target	23.33 (+29.97%)
Earnings Date	Feb 25, 2025

About OFIX

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 1,634
• Stock Exchange: NASDAQ
• Ticker Symbol: OFIX
• Website: https://www.orthofix.com

Financial Performance

In 2023, Orthofix Medical's revenue was $746.64 million, an increase of 62.06% compared to the previous year's $460.71 million. Losses were -$151.40 million, 666.6% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for OFIX stock is "Strong Buy." The 12-month stock price forecast is $23.33, which is an increase of 29.97% from the latest price.

Price Target

$23.33

(29.97% upside)

Analyst Consensus: Strong Buy